⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 3, 2024Open Access

Supplementary Figure S2 from Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer

Naryan Rustgi Sharon Wu Timothy Samec Phillip Walker Joanne Xiu Emil Lou Sanjay Goel Anwaar Saeed Ryan H. Moy

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S2 shows frequently occurring molecular co-alterations in CCNE1-amplified EGC by histological subtype

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rustgi et al. (2024) studied this question.

synapsesocial.com/papers/68e66839b6db6435875f3ff4 https://doi.org/10.1158/2767-9764.25958955

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S2 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024
2Supplementary Figure S6 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024
3Supplementary Figure S6 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024
4Supplementary Figure S3 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024
5Supplementary Figure S3 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024

More related papers

Supplementary Figure S5 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024
Supplementary Figure S5 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024
Supplementary Figure S4 from Molecular Landscape and Clinical Implication of <i>CCNE1-</i>amplified Esophagogastric Cancer2024